Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that⦠read more
Healthcare
Biotechnology
2 years
USD
Exclusive to Premium users
$3.72
Price+4.65%
$0.17
$882.300m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$15.282m
-
1y CAGR-
3y CAGR-
5y CAGR-$252.182m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.06
-
1y CAGR-
3y CAGR-
5y CAGR$122.556m
$361.645m
Assets$239.089m
Liabilities$85.492m
Debt23.6%
-0.3x
Debt to EBITDA-$185.291m
-
1y CAGR-
3y CAGR-
5y CAGR